---
title: "LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-... — FDA record Z-2721-2024 | Is It on Recall"
description: "A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose)."
url: https://isitonrecall.com/recall/fda-device-z-2721-2024-lvp-primary-administration-set-dual-inlet-low-sorbing-needle-free-port-y-site-qty-25-product-code-se/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25... — FDA record Z-2721-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 1, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion.
- **Reason**: A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).
- **Classification**: Class I
- **Recalling firm**: Fresenius Kabi USA, LLC
- **Quantity**: 180 cases/4,500 pieces
- **Agency-reported status**: Ongoing
- **Source record identifier**: Z-2721-2024

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2721-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

US Distribution to states of: CO, ID, NJ, UT.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Colorado](https://isitonrecall.com/state/colorado/)
- [Idaho](https://isitonrecall.com/state/idaho/)
- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [Utah](https://isitonrecall.com/state/utah/)

## Dates in the source

- **Report date**: Sep 11, 2024
- **Recall initiation date**: Aug 1, 2024
- **Center classification date**: Sep 4, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2721-2024%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Fresenius Kabi USA, LLC records](https://isitonrecall.com/brand/fresenius-kabi-usa-llc/)